To hear about similar clinical trials, please enter your email below
Trial Title:
The Use of Cannabis (Marijuana) and Cannabidiol (CBD) Among Cancer Patients: a Pilot Study
NCT ID:
NCT05836857
Condition:
Cancer
Conditions: Official terms:
Marijuana Abuse
Cannabidiol
Study type:
Observational
Overall status:
Active, not recruiting
Study design:
Time perspective:
Prospective
Intervention:
Intervention type:
Behavioral
Intervention name:
Cannabis (Marijuana)
Description:
The level of interest in learning more about cannabis for cancer pain, we can better
facilitate a patient-centered approach to comprehensive treatment plans through patient
education.
Arm group label:
Cannabis (Marijuana) and Cannabidiol (CBD)
Intervention type:
Behavioral
Intervention name:
Cannabidiol (CBD)
Description:
The level of interest in learning more about cannabis for cancer pain, we can better
facilitate a patient-centered approach to comprehensive treatment plans through patient
education
Arm group label:
Cannabis (Marijuana) and Cannabidiol (CBD)
Summary:
To collect information about how patients in the pain management clinic use cannabis/CBD,
including how often it is used, why it is used (for example, to manage pain or other
symptoms), and where patients get their information on cannabis/CBD for pain management
Detailed description:
Objectives
Primary Objective:
The primary objective of this study is to investigate the prevalence of current and prior
cannabis and/or CBD use in cancer patients who present to the pain management clinic at
MDACC.
Secondary Objectives:
The secondary objective is to investigate the reason for cannabis/CBD use (e.g. pain,
neuropsychiatric symptoms, recreational or other use), degree of symptom improvement with
use, frequency of use, methods of use (e.g. inhaled vs. ingested), sources of information
on cannabis/CBD, and patient interest in learning more from their physicians about
cannabis/CBD for cancer pain.
Criteria for eligibility:
Study pop:
M D Anderson Cancer Center
Sampling method:
Probability Sample
Criteria:
Inclusion Criteria:
1. Age 18 years or older
2. Cancer patients who present to the MD Anderson Pain Medicine Clinic as a new patient
or consult
3. Willing to give informed consent
4. Willing to complete the survey
Exclusion Criteria:
1. Refusal of informed consent
2. Refusal to complete the survey
3. Patients who previously completed the survey
4. Patients who opt-out or change their mind after agreeing to participate
5. Already an established patient at MDACC Pain Medicine Clinic
6. Patients scheduled to see Dr Abdi (PI).
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
M D Anderson Cancer Center
Address:
City:
Houston
Zip:
77030
Country:
United States
Start date:
January 30, 2023
Completion date:
May 31, 2025
Lead sponsor:
Agency:
M.D. Anderson Cancer Center
Agency class:
Other
Source:
M.D. Anderson Cancer Center
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05836857
http://www.mdanderson.org
